Skip to main content

Multiplicom BRCA Hereditary Cancer MASTR Plus Kit, BRCA Tumor MASTR Plus Kit

Multiplicom has released two new gene panel amplification kits for next-gen sequencing-based cancer testing.

The BRCA Hereditary Cancer MASTR Plus kit detects germline variants in 26 genes associated with hereditary cancers, and the BRCA Tumor MASTR Plus kit detects variants in the BRCA1 and BRCA2 genes in tumor biopsy material.

Initially, both kits are available for research use only, but Multiplicom has started clinical validation studies to obtain CE-IVD marking for the assays.

The Scan

Rise of B.1.617.2 in the UK

According to the Guardian, UK officials expect the B.1.617.2 variant to soon be the dominant version of SARS-CoV-2 there.

Anne Schuchat to Retire

Anne Schuchat is retiring after more than 30 years at the US Centers for Disease Control and Prevention, Politico reports.

US to Share More Vaccines

CNN reports that the US will share 20 million doses of the Moderna, Pfizer, and Johnson & Johnson SARS-CoV-2 vaccines with other countries.

PNAS Papers on Gene Therapy Platform, Aspergillus Metabolome, Undernutrition Model Microbiome

In PNAS this week: approach to deliver protein-based treatments to cells, pan-secondary metabolome of Aspergillus, and more.